Simcere Pharmaceutical Group Limited - Current Ratio

The Current Ratio as of September 2026 (TTM) for Simcere Pharmaceutical Group Limited (2096.HK) is 1.90

According to Simcere Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.90. This represents a change of -3.07% compared to the average of 1.96 of the last 4 quarters.

Simcere Pharmaceutical Group Limited (2096.HK) Historical Current Ratio (quarterly & annually)

How has 2096.HK Current Ratio performed in the past?

The mean historical Current Ratio of Simcere Pharmaceutical Group Limited over the last ten years is 1.59. The current 1.90 Current Ratio has changed 11.86% with respect to the historical average. Over the past ten years (40 quarters), 2096.HK's Current Ratio was at its highest in in the June 2023 quarter at 2.35. The Current Ratio was at its lowest in in the June 2019 quarter at 0.

Simcere Pharmaceutical Group Limited (2096.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Simcere Pharmaceutical Group Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Simcere Pharmaceutical Group Limited (2096.HK) Average Current Ratio

How has 2096.HK Current Ratio performed in the past?

The current Current Ratio of Simcere Pharmaceutical Group Limited (2096.HK) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Simcere Pharmaceutical Group Limited (2096.HK) Current Ratio vs. Peers

How is 2096.HK’s Current Ratio compared to its peers?

Simcere Pharmaceutical Group Limited’s Current Ratio is less than Asymchem Laboratories (Tianjin) Co., Ltd. (4.56), greater than Shanghai Henlius Biotech, Inc. (0.78), less than Duality Biotherapeutics, Inc. (1.99), greater than Genscript Biotech Corporation (1.48), less than China Medical System Holdings Limited (6.64), greater than China Resources Pharmaceutical Group Ltd. (1.43), greater than Livzon Pharmaceutical Group Inc. (1.55), greater than Grand Pharmaceutical Group Limited (1.34), greater than Ascentage Pharma Group International (1.22), greater than Shanghai Junshi Biosciences Co., Ltd. (1.80),

Build a custom stock screener for Simcere Pharmaceutical Group Limited (2096.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Simcere Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Simcere Pharmaceutical Group Limited (2096.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Simcere Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.